A carregar...
The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: A meta-analysis
Rituximab is considered to be a promising drug for treating childhood refractory nephrotic syndrome. However, the efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome remain inconclusive. This meta-analysis aimed to investigate the efficacy and safety of rituximab tre...
Na minha lista:
| Publicado no: | Sci Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4314653/ https://ncbi.nlm.nih.gov/pubmed/25645999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep08219 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|